Kim P. Kamdar, Director at OBALON THERAPEUTICS INC (OBLN), bought 12,500 shares at $4.00 ($50K) on 2019-08-06, disclosed to the SEC on 2019-08-08.
Open-market purchase of $50k OBLN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| EVFM | BUY | 2021-06-21 | $12K | — | Filing → |
| EVFM | BUY | 2020-06-16 | $15K | — | Filing → |
| EVFM | SELL | 2019-05-23 | $3K | — | Filing → |